Stock listing
A2P6R6 Stock Price, News, Filings & Events — Vaxcyte, Inc.
Selected listing: A2P6R6 · LS · EUR · DE
This page tracks Vaxcyte, Inc.'s A2P6R6:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P6R6:LS. A2P6R6:LS is the stock-level entry point for investors researching Vaxcyte, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2P6R6:LS
- Asset type
- Stock
- Market cap
- $8.40B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LS
- Currency
- EUR
Vaxcyte, Inc. A2P6R6:LS stock context
This page tracks Vaxcyte, Inc.'s A2P6R6:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P6R6:LS. A2P6R6:LS is the stock-level entry point for investors researching Vaxcyte, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Vaxcyte, Inc.
Vaxcyte to Host Webcast and Conference Call to Present Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
October 4, 2026
Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data
September 3, 2026
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026
Vaxcyte to Participate in Upcoming Investor Conferences
July 8, 2026
Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults
June 2, 2026
Vaxcyte, Inc. earnings calls
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call
February 24, 2026 · Replay with transcript and chapters
Vaxcyte, Inc. (PCVX) Q4 2024 Earnings Call
February 25, 2025 · Replay with transcript and chapters
Vaxcyte, Inc. (PCVX) Q4 2023 Earnings Call
February 27, 2024 · Replay with transcript and chapters
Vaxcyte, Inc. (PCVX) Q4 2022 Earnings Call
February 27, 2023 · Replay with transcript and chapters
Vaxcyte, Inc. (PCVX) Q4 2021 Earnings Call
February 28, 2022 · Replay with transcript and chapters
Research Vaxcyte, Inc.
Vaxcyte, Inc. investor report
Review AI stock analysis and investor report context for A2P6R6:LS.
Vaxcyte, Inc. company profile
View the public company page for Vaxcyte, Inc. on 6ix.
Vaxcyte, Inc. news
Read company news and market updates connected to Vaxcyte, Inc..
Vaxcyte, Inc. investor events
Find investor webinars, events, and replay context for Vaxcyte, Inc..
Alternate listings
PCVX:NASDAQ
US · USD
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
5VA:GETTEX
DE · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
A2P6R6:LSX
DE · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
1PCVX:MIL
IT · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
PCVX:BOATS
US · USD
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
5VA:FWB
DE · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
PCVX:BX
CH · CHF
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
5VA:DUS
DE · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
5VA:HAM
DE · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
5VA:MUN
DE · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
5VA:SWB
DE · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.
5VA:TRADEGATE
DE · EUR
Alternate listing for Vaxcyte, Inc.; the primary context on this page is A2P6R6:LS.